Home > SWOT Analysis > Amylin Pharma (AMLN) SWOT Analysis





Amylin Pharma (AMLN) SWOT Analysis Profile

Amylin Pharmaceuticals, Inc., founded in 1987, is a biopharmaceutical company that discovers and develops medicines for diabetes, obesity, and other diseases in the United States. Based in San Diego, California, Amylin Parmaceuticals, Inc. sells its products to healthcare providers, managed healthcare organizations, wholesalers and pharmacies, and others, and partners with a number of firms in research and marketing of therapeutic products for a range of diseases. (read full profile)

Additional Information

What is a SWOT Analysis? It is a way of evaluating the strengths, weaknesses, opportunities, and threats that affect something. See WikiWealth's SWOT tutorial for help. Remember, vote up the most important comments. Check out WikiWealth's entire database of free SWOT reports or use our SWOT analysis generator to create your own SWOT template.

Receive News & Ratings Via Email